As we look at the diagnostic trends of 2026, the demand for non-invasive testing is driving a surge in the use of surface markers for "liquid biopsies." By detecting specific antigens on circulating tumor cells (CTCs) found in the blood, clinicians can now monitor cancer progression without the need for painful and risky surgical biopsies. The Cell Surface Markers Market is playing a pivotal...

10 robotic exoskeleton pilots transforming post-stroke hemiplegia care in 2026 The dawn of 2026 has brought a decisive shift in neuro-rehabilitation protocols as the Ministry of Health and Family Welfare in India initiates large-scale trials for wearable robotic systems. These pilots aim to address the chronic mobility deficits associated with unilateral paralysis by integrating...